TGF-beta-induced	JJ
EMT	NN
:	:
mechanisms	NNS
and	CC
implications	NNS
for	IN
fibrotic	JJ
lung	NN
disease	NN
.	.

Epithelial-mesenchymal	JJ
transition	NN
(	(
EMT	NN
)	)
,	,
a	DT
process	NN
whereby	WRB
fully	RB
differentiated	VBN
epithelial	JJ
cells	NNS
undergo	VBP
transition	NN
to	TO
a	DT
mesenchymal	JJ
phenotype	NN
giving	VBG
rise	NN
to	TO
fibroblasts	NNS
and	CC
myofibroblasts	NNS
,	,
is	VBZ
increasingly	RB
recognized	VBN
as	IN
playing	VBG
an	DT
important	JJ
role	NN
in	IN
repair	NN
and	CC
scar	NN
formation	NN
following	VBG
epithelial	JJ
injury	NN
.	.

The	DT
extent	NN
to	TO
which	WDT
this	DT
process	NN
contributes	VBZ
to	TO
fibrosis	NN
following	VBG
injury	NN
in	IN
the	DT
lung	NN
is	VBZ
a	DT
subject	NN
of	IN
active	JJ
investigation	NN
.	.

Recently	RB
,	,
it	PRP
was	VBD
demonstrated	VBN
that	IN
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
beta	NN
induces	VBZ
EMT	NNP
in	IN
alveolar	JJ
epithelial	JJ
cells	NNS
(	(
AEC	NNS
)	)
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
,	,
and	CC
epithelial	JJ
and	CC
mesenchymal	JJ
markers	NNS
have	VBP
been	VBN
colocalized	VBN
to	TO
hyperplastic	JJ
type	NN
II	CD
(	(
AT2	NN
)	)
cells	NNS
in	IN
lung	NN
tissue	NN
from	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
,	,
suggesting	VBG
that	IN
AEC	NNP
may	MD
exhibit	VB
extreme	JJ
plasticity	NN
and	CC
serve	VB
as	IN
a	DT
source	NN
of	IN
fibroblasts	NNS
and/or	CC
myofibroblasts	NNS
in	IN
lung	NN
fibrosis	NN
.	.

In	IN
this	DT
review	NN
,	,
we	PRP
describe	VBP
the	DT
characteristic	JJ
features	NNS
of	IN
EMT	NN
and	CC
its	PRP$
mechanistic	JJ
underpinnings	NNS
.	.

We	PRP
further	RB
describe	VBP
the	DT
contribution	NN
of	IN
EMT	NN
to	TO
fibrosis	NN
in	IN
adult	JJ
tissues	NNS
following	VBG
injury	NN
,	,
focusing	VBG
especially	RB
on	IN
the	DT
critical	JJ
role	NN
of	IN
TGF-beta	NN
and	CC
its	PRP$
downstream	JJ
mediators	NNS
in	IN
this	DT
process	NN
.	.

Finally	RB
,	,
we	PRP
highlight	VBP
recent	JJ
descriptions	NNS
of	IN
EMT	NN
in	IN
the	DT
lung	NN
and	CC
the	DT
potential	JJ
implications	NNS
of	IN
this	DT
process	NN
for	IN
the	DT
treatment	NN
of	IN
fibrotic	JJ
lung	NN
disease	NN
.	.

Treatment	NN
for	IN
fibrosis	NN
of	IN
the	DT
lung	NN
in	IN
diseases	NNS
such	JJ
as	IN
IPF	NN
has	VBZ
heretofore	RB
focused	VBN
largely	RB
on	IN
amelioration	NN
of	IN
potential	JJ
inciting	VBG
processes	NNS
such	JJ
as	IN
inflammation	NN
.	.

It	PRP
is	VBZ
hoped	VBN
that	IN
this	DT
review	NN
will	MD
stimulate	VB
further	JJ
consideration	NN
of	IN
the	DT
cellular	JJ
mechanisms	NNS
of	IN
fibrogenesis	NN
in	IN
the	DT
lung	NN
and	CC
especially	RB
the	DT
role	NN
of	IN
the	DT
epithelium	NN
in	IN
this	DT
process	NN
,	,
potentially	RB
leading	VBG
to	TO
innovative	JJ
avenues	NNS
of	IN
investigation	NN
and	CC
treatment	NN
.	.

